Enlivex Therapeutics Ltd. (ENLV) NASDAQ

1.06

+0.02(+1.92%)

Updated at October 03 04:00PM

Currency In USD

Enlivex Therapeutics Ltd.

Address

14 Einstein Street

Ness Ziona, 7403618

Israel

Phone

972 8 662 3301

Sector

Healthcare

Industry

Biotechnology

Employees

71

First IPO Date

July 31, 2014

Key Executives

NameTitlePayYear Born
Dr. Oren Hershkovitz Ph.D.Chief Executive Officer273,6001977
Ms. Shachar Shlosberger CPAChief Financial Officer126,0001977
Prof. Dror Mevorach M.D.Founder & Scientific Advisor180,0001956
Mr. Shai Novik M.B.A.Executive Chairman528,0001966
Ms. Sigal AradDirector of Human Resources0N/A
Dr. Einat Galamidi M.D.Chief Medical Officer01974
Dr. Veronique Amor-BaroukhSenior Director of Operations0N/A

Description

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.